OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Gastroenterology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Editorial introductions	63
Small varices in chronic liver diseases	53
Hepatitis E virus: has anything changed?	35
Cholangioscopy for biliary diseases	32
Updates and innovations in therapeutic endoscopy	30
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis	28
Clostridioides difficile infections; new treatments and future perspectives	28
Editorial introductions	26
Biologics, small molecule therapies and surgery in small bowel Crohn's disease	25
Medical malpractice and gastrointestinal endoscopy	24
Using nutrition to help recovery from infections	24
Mucosal defense: gastroduodenal injury and repair mechanisms	24
Stomach and duodenum: what's current in 2023	23
Double-edged sword: impact of fecal microbiome transplants on the gut resistome	23
Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease	19
Editorial introductions	17
Current and future microbiome-based therapies in inflammatory bowel disease	17
Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective	16
Carnitine derivatives beyond fatigue: an update	16
Considerations when starting patients on multiple biologics and small molecules	15
COVID-19 vaccine-induced liver injury	15
Small bowel lymphoma: clinical update and challenges for the gastroenterologist	15
A brave new world: the gastrointestinal lab during and after a pandemic	15
Interactions between the environmental and human microbiota in the preservation of health and genesis of disease: symposium report	13
The gut virome in health and disease: new insights and associations	13

Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet	13
Editorial: Clinical and pathogenic novelties in cholangiopathies: new treatments and many more to come	13
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging	13
Prognostic modeling in biliary diseases	12
Implications of Paneth cell dysfunction on gastrointestinal health and disease	11
Gastroparesis: time for a paradigm change	11
Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections	11
Cryptogenic multifocal ulcerating stenosing enteritis and other under-recognised small bowel inflammatory enteropathies	11
Gastric submucosal mass lesions	11
Clinical and translational markers of severity and prognosis in chronic pancreatitis	11
Breastfeeding and the developmental origins of mucosal immunity: how human milk shapes the innate and adaptive mucosal immune systems	11
Tight junction proteins and biliary diseases	10
Bidirectional relationship between acute pancreatitis and pancreatic cancer	10
Endoscopic management of colonic perforations	10
Laparoscopic heller myotomy versus peroral endoscopic myotomy for the treatment of achalasia	10
Endoluminal bariatric and metabolic therapies: state-of-the-art	10
Advances in endoscopic management of colonic diverticular bleeding	10
Ergonomic wellness for the trainee in gastrointestinal endoscopy	10
Machine and deep learning in inflammatory bowel disease	10
Celiac disease and nonceliac enteropathies	10
Role of albumin in the treatment of decompensated liver cirrhosis	10
Editorial introductions	9
Artificial intelligence within the small bowel: are we lagging behind?	9
Managing the older adult with inflammatory bowel disease: is age just a number?	9
Intestinal proteases	9
Alterations in microbiome associated with acute pancreatitis	9
Bile acid diarrhea – as bad as it gets?	9
Diagnosis and management of acute lower gastrointestinal bleeding	9
Nutritional aspects in patients with gastroparesis	9
The rise of antibiotic resistance in Campylobacter	8
Histological evaluation in biliary diseases	8
Endoscopic approaches to the management of hemorrhoids	8
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness	8
Advances in the evaluation and treatment of autoimmune hepatitis	8
Updates on therapeutic endoscopic ultrasound	8
Should high-fiber diets be recommended for patients with inflammatory bowel disease?	7
Editorial introductions	7
Editorial: Advances in hepatology: 2022	7
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment	7
Third space endoscopy: the future of treating gastrointestinal dysmotility	7
The spectrum of diabetes in acute and chronic pancreatitis	7
Pathophysiology updates: gastroduodenal injury and repair mechanisms	7
Check this out: treatment paradigms in immune-checkpoint inhibitor colitis	7
The status of endoscopic therapies for gastroesophageal reflux disease	7
Endoscopic approaches to small intestinal strictures	7
Updates in endoscopic management of ampullary and duodenal adenomas	7
Diet and carcinogenesis of gastric cancer	7
Update on applications of endoscopic cryotherapy in the gastrointestinal tract	7
Integrating new and emerging therapies into inflammatory bowel disease clinical practice	7